Status:
RECRUITING
An Observational Study on the Identification of Prescription Patterns of STAFEN Cap
Lead Sponsor:
Hanlim Pharm. Co., Ltd.
Conditions:
Mixed Dyslipidemia
Eligibility:
All Genders
19+ years
Brief Summary
An observational study on the identification of prescription patterns of STAFEN Cap., changes in blood lipid concentration, and statin-related muscle symptoms in Korean patients with mixed dyslipidemi...
Detailed Description
This study aims to observe the effectiveness of STAFEN capsule such as changes in blood lipid concentration and safety including statin-related muscle symptoms, and prescription patterns under daily c...
Eligibility Criteria
Inclusion
- Adults over 19 years of age
- A patient diagnosed with mixed dyslipidemia
- A patient who was first prescribed a STAFEN cap. for the purpose of treating mixed dyslipidemia according to the clinician's judgment
- A patient who voluntarily agreed in writing to this study
Exclusion
- Pregnant women, lactating women, or those planning to conceive
- A person who is prohibited from administering the STAFEN cap. under the permit
- If the person in charge of other clinical studies and the person in charge deems it inappropriate to be the subject of this clinical study
Key Trial Info
Start Date :
April 21 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT06204380
Start Date
April 21 2021
End Date
November 30 2024
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Delphoe Clinic
Gangneung-si, South Korea